Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00407147 · ClinicalTrials.gov registry record · Phase 4
Procalcitonin Level to Discontinue Antibiotics on ICU Patients With no Obvious Site of Infection
A Phase 4 study, sponsored by Brahms.
- Terminated
- Registry status
- Phase 4
- Development phase
- 11
- Enrollment target
NCT00407147 is a Phase 4 study that was terminated before completion, run by Brahms. The registered enrollment target is 11 participants.
The verdict
NCT00407147, a Phase 4 study, was terminated before completion, sponsored by Brahms.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 11 participants
- Enrollment target
Study Summary
The purpose of this study is to test whether a U.S. Food and Drug Administration (FDA) approved laboratory test (PCT Kryptor) can help doctors make better decisions on the need for antibiotic therapy in ICU patients with suspected infections.
Interventions
- DEVICE Procalcitonin assay - B.R.A.H.M.S PCT sensitive Kryptor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2008-07 |
| Est. Completion | 2009-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00407147
The ClinicalTrials.gov registry entry for NCT00407147 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Brahms, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Procalcitonin assay - B.R.A.H.M.S PCT sensitive Kryptor is the first listed.
NCT00407147 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00407147 about?
NCT00407147 is a clinical study titled "Procalcitonin Level to Discontinue Antibiotics on ICU Patients With no Obvious Site of Infection". The purpose of this study is to test whether a U.S. Food and Drug Administration (FDA) approved laboratory test (PCT Kryptor) can help doctors make better decisions on the need for antibiotic therapy in ICU patients with suspected infections.
What is the current status of trial NCT00407147?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 11 participants. The study started on 2008-07. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00407147?
The interventions under investigation include: Procalcitonin assay - B.R.A.H.M.S PCT sensitive Kryptor (DEVICE).
Who is sponsoring clinical trial NCT00407147?
This trial is sponsored by Brahms, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.